Status:

COMPLETED

The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry Sponsor

Lead Sponsor:

National Human Genome Research Institute (NHGRI)

Conditions:

Duchenne Muscular Dystrophy

Eligibility:

All Genders

18-99 years

Brief Summary

The purpose of this study is to describe the experiences of parents, clinician researchers, and industry professionals who were involved in phase II clinical trials of Ataluren for Duchenne muscular d...

Detailed Description

Some aspects of the traditional process for the development of new potential therapeutics for rare disorders and the ensuing research on safety and efficacy are changing. This is due, in part, to the ...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • US residents over 18 years of age who have at least one child with Duchenne Muscular Dystrophy who was enrolled in the phase IIa extension trial or phase IIb trial of PTC124. Participants must be a primary caregiver for their children, must have been involved in deciding whether the child would participate in the clinical trial, and must have accompanied their child to at least one visit to the clinical trial site.
  • Clinician researchers over 18 years of age who were involved with implementing the clinical trial at a study site.
  • Representatives of PTC Therapeutics over 18 years of age.
  • All participants must be willing and able to complete an approximately 1-hour long telephone interview in English.
  • EXCLUSION CRITERIA:
  • Must meet inclusion criteria.

Exclusion

    Key Trial Info

    Start Date :

    July 30 2010

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    June 24 2013

    Estimated Enrollment :

    21 Patients enrolled

    Trial Details

    Trial ID

    NCT01182324

    Start Date

    July 30 2010

    End Date

    June 24 2013

    Last Update

    April 5 2018

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Human Genome Research Institute (NHGRI), 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892